Reference
WHO Pharmaceuticals NEWSLETTER - Regulatory Matters: Gabapentin WHO Pharmaceuticals Newsletter : No. 1, 2023. Available from: URL: https://www.who.int/publications/i/item/9789240070240
Rights and permissions
About this article
Cite this article
Gapapentin-related drug dependence and withdrawal symptoms. Reactions Weekly 1949, 4 (2023). https://doi.org/10.1007/s40278-023-35984-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-35984-y